Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1984-2-14
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Aclarubicin, http://linkedlifedata.com/resource/pubmed/chemical/Aminoacridines, http://linkedlifedata.com/resource/pubmed/chemical/Amsacrine, http://linkedlifedata.com/resource/pubmed/chemical/Anthraquinones, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Azacitidine, http://linkedlifedata.com/resource/pubmed/chemical/Etoposide, http://linkedlifedata.com/resource/pubmed/chemical/Ifosfamide, http://linkedlifedata.com/resource/pubmed/chemical/Interferons, http://linkedlifedata.com/resource/pubmed/chemical/Liposomes, http://linkedlifedata.com/resource/pubmed/chemical/Mitoxantrone, http://linkedlifedata.com/resource/pubmed/chemical/Naphthacenes, http://linkedlifedata.com/resource/pubmed/chemical/Teniposide, http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine, http://linkedlifedata.com/resource/pubmed/chemical/Vindesine, http://linkedlifedata.com/resource/pubmed/chemical/aclacinomycins
pubmed:status
MEDLINE
pubmed:issn
0065-230X
pubmed:author
pubmed:issnType
Print
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
255-329
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:6197869-Aclarubicin, pubmed-meshheading:6197869-Acute Disease, pubmed-meshheading:6197869-Adolescent, pubmed-meshheading:6197869-Adult, pubmed-meshheading:6197869-Age Factors, pubmed-meshheading:6197869-Aminoacridines, pubmed-meshheading:6197869-Amsacrine, pubmed-meshheading:6197869-Anthraquinones, pubmed-meshheading:6197869-Antibodies, Monoclonal, pubmed-meshheading:6197869-Azacitidine, pubmed-meshheading:6197869-Bone Marrow Transplantation, pubmed-meshheading:6197869-Child, pubmed-meshheading:6197869-Child, Preschool, pubmed-meshheading:6197869-Drug Administration Schedule, pubmed-meshheading:6197869-Etoposide, pubmed-meshheading:6197869-Humans, pubmed-meshheading:6197869-Ifosfamide, pubmed-meshheading:6197869-Immunotherapy, pubmed-meshheading:6197869-Infant, pubmed-meshheading:6197869-Interferons, pubmed-meshheading:6197869-Leukemia, pubmed-meshheading:6197869-Leukemia, Lymphoid, pubmed-meshheading:6197869-Liposomes, pubmed-meshheading:6197869-Middle Aged, pubmed-meshheading:6197869-Mitoxantrone, pubmed-meshheading:6197869-Naphthacenes, pubmed-meshheading:6197869-Prognosis, pubmed-meshheading:6197869-Teniposide, pubmed-meshheading:6197869-Transplantation, Homologous, pubmed-meshheading:6197869-Transplantation, Isogeneic, pubmed-meshheading:6197869-Vinblastine, pubmed-meshheading:6197869-Vindesine
pubmed:year
1983
pubmed:articleTitle
Treatment of acute leukemia--advances in chemotherapy, immunotherapy, and bone marrow transplantation.
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't